CMS Pub. 100-18, ch. 7, § 30.5

A Part D sponsor must—

• Describe in its application how it takes into account the resources used and time required

to implement the MTMP it chooses to adopt in establishing fees for pharmacists or others

providing MTMP services for covered Part D drugs under a Part D plan.

• Disclose to CMS, upon request, the amount of the management and the portion paid for

MTMP services to pharmacists and others upon request. Reports of these amounts are

protected under the confidentiality provisions of section 1927(b)(3)(D) of the Act.

Individual plans determine fees associated with providing MTMPs, which may include services

offered by pharmacists or other providers. Part D sponsors will have the flexibility to establish

their own fees, but must take into account the time and resources associated with implementing

the MTMP. CMS will require potential Part D sponsors to explain, as part of their application,

how their fees account for the time and resources associated with their medication therapy

management program.

CMS considers MTMP services provided to targeted beneficiaries as an administrative cost

(included in the plan bid), incident to appropriate drug therapy, and not an additional benefit.